brentuximab vedotin

Also known as SGN-35, cAC10-vcMMAE, brentuximab, Adcetris

protéine

Research

1,832 papers

Brentuximab vedotin in T-cell lymphoma.Expert review of hematology · 2019
Brentuximab vedotin.mAbs · 2012
Brentuximab vedotin.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.Frontiers in immunology · 2023
Brentuximab vedotin.Drugs in R&D · 2011

via PubMed

Article · Français

Le brentuximab védotine est la combinaison d'un anticorps monoclonal dirigé contre le CD30 et un antimitotique, permettant ce dernier d'agir spécifiquement sur la cellule porteuse du CD30.

Abstract from DBpedia / Wikipedia · CC BY-SA

Available in 13 languages

Connections

Similar entities

Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).

benzofuranylpropylaminopentane

(4aR,10bR)-4-propyl-3,4a,5,10b-tetrahydro-2H-[1]benzopyrano[4,3-b][1,4]oxazin-9-ol

Entitydist 0.57

α-pyrrolidinopropiophenone

Entitydist 0.57

EEDQ

Entitydist 0.57

(RS)-aminoglutethimide

Entitydist 0.57

benocyclidine

Entitydist 0.58

brentuximab vedotin

Research

Article · Français

Available in 13 languages

Connections

What links here371 pages

Similar entities

Categories

Similar entities

What links here371 pages